Email updates

Keep up to date with the latest news and content from BMC Complementary and Alternative Medicine and BioMed Central.

Open Access Highly Accessed Research article

Electroacupuncture versus Diclofenac in symptomatic treatment of Osteoarthritis of the knee: a randomized controlled trial

Chaichan Sangdee1*, Supanimit Teekachunhatean1, Kanit Sananpanich2, Nantawit Sugandhavesa2, Siripong Chiewchantanakit2, Suwalee Pojchamarnwiputh3 and Subhachai Jayasvasti3

Author Affiliations

1 Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Thailand

2 Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Thailand

3 Department of Radiology, Faculty of Medicine, Chiang Mai University, Thailand

For all author emails, please log on.

BMC Complementary and Alternative Medicine 2002, 2:3  doi:10.1186/1472-6882-2-3

Published: 21 March 2002

Abstract

Background

The purpose of this study was to compare the efficacy of electroacupuncture (EA), diclofenac and their combination in symptomatic treatment of osteoarthritis (OA) of the knee.

Methods

This study was a randomized, single-blind, placebo controlled trial. The 193 out-patients with OA of the knee were randomized into four groups: placebo, diclofenac, EA and combined (diclofenac plus EA). Paracetamol tablets were prescribed as a rescue analgesic during the study. The patients were evaluated after a run-in period of one week (week 0) and again at the end of the study (week 4). The clinical assessments included the amount of paracetamol taken/week, visual analog scale (VAS), Western Ontario and McMaster Universities (WOMAC) OA Index, Lequesne's functional index, 50 feet-walk time, and the orthopedist's and patient's opinion of change.

Results

One hundred and eighty six patients completed the study. The improvement of symptoms (reduction in mean changes) in most outcome parameters was greatest in the EA group. The proportions of responders and patients with an overall opinion of "much better" were also greatest in the EA group. The improvement in VAS was significantly different between the EA and placebo group as well as the EA and diclofenac group. The improvement in Lequesne's functional index also differed significantly between the EA and placebo group. In addition, there was a significant improvement in WOMAC pain index between the combined and placebo group.

Conclusion

EA is significantly more effective than placebo and diclofenac in the symptomatic treatment of OA of the knee in some circumstances. However, the combination of EA and diclofenac treatment was no more effective than EA treatment alone.